M20-466

Brief Summary:

This study is a randomized, double-blinded study to evaluate the safety and efficacy of ABBV-154 in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to Biologic and/or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs.

View The Flyer For This Study

View The Patient Letter For This Study

Click Here To Learn More

 

INTERESTED IN THIS STUDY?  CLICK HERE TO CONTACT US.